famotidine has been researched along with Eosinophilic Esophagitis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Eosinophilic Esophagitis: Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odiase, E | 1 |
| Zhang, X | 1 |
| Chang, Y | 1 |
| Nelson, M | 1 |
| Balaji, U | 1 |
| Gu, J | 1 |
| Zhang, Q | 1 |
| Pan, Z | 1 |
| Spechler, SJ | 1 |
| Souza, RF | 1 |
1 other study available for famotidine and Eosinophilic Esophagitis
| Article | Year |
|---|---|
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
Topics: Biological Transport; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Line; Chemokine CCL26 | 2021 |